30/12/2025
Led by ICMR–NIRRCH, in collaboration with ISAR, IFS and ACE, the experts reviewed global evidence and concluded that niPGT is not yet ready for clinical embryo selection. Current data show important limitations in accuracy and no data on its benefit in improving pregnancy or live birth outcomes.
This statement supports evidence-based, patient-centred decision-making and cautions against the premature use of unvalidated technologies in IVF practice.
Full text: https://journals.lww.com/jhrs/fulltext/2025/10000/clinical_use_of_non_invasive_preimplantation.2.aspx